AU640171B2 - Cyclic peroxyacetal lactone, lactol and ether compounds - Google Patents
Cyclic peroxyacetal lactone, lactol and ether compounds Download PDFInfo
- Publication number
- AU640171B2 AU640171B2 AU64475/90A AU6447590A AU640171B2 AU 640171 B2 AU640171 B2 AU 640171B2 AU 64475/90 A AU64475/90 A AU 64475/90A AU 6447590 A AU6447590 A AU 6447590A AU 640171 B2 AU640171 B2 AU 640171B2
- Authority
- AU
- Australia
- Prior art keywords
- acid
- give
- compound
- oxygenation
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002596 lactones Chemical class 0.000 title claims description 10
- 150000002170 ethers Chemical class 0.000 title claims description 3
- 125000004122 cyclic group Chemical group 0.000 title description 7
- 238000000034 method Methods 0.000 claims description 76
- -1 cyclic acetal Chemical class 0.000 claims description 66
- PLQMEXSCSAIXGB-SAXRGWBVSA-N (+)-artemisinic acid Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(=C)C(O)=O)[C@H]21 PLQMEXSCSAIXGB-SAXRGWBVSA-N 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 51
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims description 46
- 229930101531 artemisinin Natural products 0.000 claims description 46
- 229930183339 qinghaosu Natural products 0.000 claims description 42
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 230000008569 process Effects 0.000 claims description 40
- 238000006213 oxygenation reaction Methods 0.000 claims description 38
- 239000003054 catalyst Substances 0.000 claims description 37
- IGEBZMMCKFUABB-UHFFFAOYSA-N Artemisitene Natural products O1C(OO2)(C)CCC3C(C)CCC4C32C1OC(=O)C4=C IGEBZMMCKFUABB-UHFFFAOYSA-N 0.000 claims description 28
- IGEBZMMCKFUABB-KPHNHPKPSA-N artemisitene Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)C4=C IGEBZMMCKFUABB-KPHNHPKPSA-N 0.000 claims description 28
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 23
- 239000010949 copper Substances 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- JYGAZEJXUVDYHI-UHFFFAOYSA-N dihydroartemisininic acid Natural products C1CC(C)=CC2C(C(C)C(O)=O)CCC(C)C21 JYGAZEJXUVDYHI-UHFFFAOYSA-N 0.000 claims description 21
- JYGAZEJXUVDYHI-DGTMBMJNSA-N dihydroartemisinic acid Chemical compound C1CC(C)=C[C@@H]2[C@H]([C@@H](C)C(O)=O)CC[C@@H](C)[C@@H]21 JYGAZEJXUVDYHI-DGTMBMJNSA-N 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 17
- 239000002184 metal Substances 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 16
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- NFHMBUNSGVNWDK-LMXFHCPWSA-N deoxoqinghaosu Chemical compound O1OC[C@H](C)C=C2C[C@@H](C)CC3C12CO[C@](C)(O)C3 NFHMBUNSGVNWDK-LMXFHCPWSA-N 0.000 claims description 11
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 10
- 150000002432 hydroperoxides Chemical class 0.000 claims description 10
- 238000002955 isolation Methods 0.000 claims description 10
- 150000001241 acetals Chemical class 0.000 claims description 9
- 230000011987 methylation Effects 0.000 claims description 9
- 238000007069 methylation reaction Methods 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 229910052723 transition metal Inorganic materials 0.000 claims description 9
- 150000003624 transition metals Chemical class 0.000 claims description 9
- 239000003377 acid catalyst Substances 0.000 claims description 8
- QVLQKWQNKGVECJ-UHFFFAOYSA-N copper;propanoic acid Chemical compound [Cu].CCC(O)=O QVLQKWQNKGVECJ-UHFFFAOYSA-N 0.000 claims description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-M hydroperoxide group Chemical group [O-]O MHAJPDPJQMAIIY-UHFFFAOYSA-M 0.000 claims description 8
- 239000011968 lewis acid catalyst Substances 0.000 claims description 8
- 230000001590 oxidative effect Effects 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- PLQMEXSCSAIXGB-UHFFFAOYSA-N artemisininic acid Natural products C1=C(C)CCC2C(C)CCC(C(=C)C(O)=O)C21 PLQMEXSCSAIXGB-UHFFFAOYSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 230000001706 oxygenating effect Effects 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 125000001867 hydroperoxy group Chemical group [*]OO[H] 0.000 claims description 5
- LZMOBPWDHUQTKL-RWMBFGLXSA-N artemisinic acid Natural products CC1=C[C@@H]2[C@@H](CCC[C@H]2C(=C)C(=O)O)CC1 LZMOBPWDHUQTKL-RWMBFGLXSA-N 0.000 claims description 4
- 229960004191 artemisinin Drugs 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 239000013067 intermediate product Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical class [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 claims description 2
- JAWGVVJVYSANRY-UHFFFAOYSA-N cobalt(3+) Chemical class [Co+3] JAWGVVJVYSANRY-UHFFFAOYSA-N 0.000 claims description 2
- BOQMASYCUFVXCR-LHJKONGQSA-N deoxoartemisinin Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC[C@@H]4C BOQMASYCUFVXCR-LHJKONGQSA-N 0.000 claims description 2
- 125000001033 ether group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 238000006257 total synthesis reaction Methods 0.000 claims description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical class [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims 9
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims 8
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims 7
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 1
- 101100403145 Danio rerio mul1a gene Proteins 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 125000002723 alicyclic group Chemical group 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 150000002790 naphthalenes Chemical class 0.000 claims 1
- 230000000707 stereoselective effect Effects 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical class CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 63
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 59
- 239000000203 mixture Substances 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
- 229910052760 oxygen Inorganic materials 0.000 description 15
- 239000001301 oxygen Substances 0.000 description 15
- 238000007363 ring formation reaction Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 239000003208 petroleum Substances 0.000 description 12
- 238000003818 flash chromatography Methods 0.000 description 11
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 9
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 7
- 150000004702 methyl esters Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 229960000981 artemether Drugs 0.000 description 5
- 229960002970 artemotil Drugs 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- LNQCJIZJBYZCME-UHFFFAOYSA-N iron(2+);1,10-phenanthroline Chemical compound [Fe+2].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 LNQCJIZJBYZCME-UHFFFAOYSA-N 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003430 antimalarial agent Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000005580 one pot reaction Methods 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000001405 Artemisia annua Nutrition 0.000 description 3
- 240000000011 Artemisia annua Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 150000004696 coordination complex Chemical class 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 description 2
- 238000007171 acid catalysis Methods 0.000 description 2
- 230000000078 anti-malarial effect Effects 0.000 description 2
- NLYNIRQVMRLPIQ-XQLAAWPRSA-N artemotil Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OCC)O[C@H]4[C@]32OO[C@@]1(C)O4 NLYNIRQVMRLPIQ-XQLAAWPRSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 101100327398 Anopheles gambiae CecA gene Proteins 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 101100059601 Ceratitis capitata CEC1 gene Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 101100336468 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gem-1 gene Proteins 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000002009 alkene group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- SEKCXMNFUDONGJ-UHFFFAOYSA-L copper;2-ethylhexanoate Chemical class [Cu+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O SEKCXMNFUDONGJ-UHFFFAOYSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 101150109337 hydN gene Proteins 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005657 iodolactonization reaction Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000007124 photooxygenation reaction Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Description
WO 91/04970 PCT/AU90/00456 CYCLIC PEROXYACETAL LACTONE, LACTOL AND ETHER COMPOUNDS Technical Field This invention relates to a new process for preparing cyclic peroxyacetal lactone, lactol or ether compounds.
Background of the Invention The present invention is particularly important in its application to the preparation of biologically active compounds comprising the cyclic peroxyacetal lactone or lactol functionalities.
One such biologically active compound is qinghaosu (Artemisinin) which has the following formula: o-o H H 0 0 Qinghaosu is a potent antimalarial which has been successfully used to treat patients suffering from malaria.
The reemergence of strains of malaria resistant to conventional (chloroquine) therapy is posing a worldwide problem, and indeed, there is no universally acceptable cure at the present time. Qinghaosu occurs to the extent of about 0.1 (dry weight) in an annual shrub, qinghao or (Artemisia annua) which grows in most provinces of China.
Unfortunately, the world demand for qinghaosu far exceeds the supply, and there is considerable pressure to develop bioactive analogues, or to develop alternative sources for the compound. The compound has been prepared by total synthesis in the laboratory, but the structural complexity is such that no total laboratory synthesis has been economically feasible.
WO 91/04970 In preparing a) b) c) 2 PCT/AU90/00456 The Disclosure of the Invention one aspect, the invention provides a process for a compound containing: peroxyacetal lactone peroxyacetal lactol or peroxyacetal ether functionality comprising oxygenating a compound containing: i) ii) iii) iv) v) hydroperoxy alkene carboxylic acid hydroperoxy alkene aldehyde hydroperoxy alkene keto or hydroperoxy alkene alcohol functionality dialkyl acetals of compounds in ii) and iii) above in the presence of one or more oxidizing metal catalysts.
The process of the present invention can be carried out as a "one-pot" reaction, referred to as the direct method or by a series of steps, referred to as the indirect method.
In particular, the direct method involves oxygenation of a compound of formula (CH2)m (Y)p HOO O (X)n
R
in the presence of one or more oxidizing metal catalysts to give a compound of formula (CH,)m (o-oN O (X)n R7 3 wherein n 1, 2 or 3 m 0, 1 or 2 p 0, 1, 2 or 3
OR
1
R
5 -COOH, -CROH, -C-R \0R 1 where R is H, alkyl, aryl or arylalkyl
R
1 are independently alkyl, aryl or arylalkyl or each R 1 together with the group to which they are attached form a cyclic acetal X CR 2
R
3
C=CR
2
R
3 S SO or SO2 where R 2 and R 3 are independently selected from H, optionally substituted alkyl, optionally substituted aryl, the optional substituents being selected from alkyl, aryl, halogen, OR, CF 3
NO
2 COR, NRR', SR, COOR, CONRR', S0 3 R, SO 2 NRR', SR, SOR and SO 2 R, where R and R' are as defined for R above; SR", SOR", S02R" where R" is alkyl or aryl optionally substituted by one or more substitutents selected from alkyl, aryl, halogen, OR, CF 3
NO
2 COR, NRR', SR, COOR, CONRR', SO 3
R,
SO
2 NRR', SR, SOR and SO 2 R, where R and R' are as defined for R above; and wherein when n>l, X is independently selected and can be branched or straight chain and X together with a substituent Y can also form a ring; Y is a substituent selected from H; alkyl or aryl optionally substituted by one or more sustituents selected from alkyl, aryl, halogen, OR, CF 3
NO
2 COR, NRR', SR, COOR, CONRR', SO 3 R, S02NRR', SR, SOR and SO 2 R, where R and R' are as defined for R above; 04828-TQ/3.2.93 4 Y can be on the same C atom as the hydroperoxy group and any C atom may be disubstituted by Y and includes replacement of H atom(s) in "(CH2)m" by Y;
R
6 or R 7 is as defined for R above, H, OH, OR 1 or together with the carbon atom to which they are attached form a keto group.
The direct method involves oxygenation of the hydroperoxy compound in the presence of one or more catalysts to undergo a new oxygenation-cleavagecyclization reaction to give a cyclic peroxyacetal lactone, lactol or ether compound. Optionally, a protic acid or lewis acid catalyst may be added.
According to IUPAC nomenclature, acetals derived from acids, ketones, aldehydes are all called "acetals".
However, it is common to name an acetal derived from a ketone, a "ketal". Thus, it is to be understood that the term "acetal" also includes within its scope acetals derived from ketones ie. ketals.
The skilled addressee would understand that the process of the invention may result in one or more stereogenic (chiral) centres being formed resulting in stereoisomers.
Thus, it is to be understood that the present invention includes within its scope the preparation of stereoisomerg. The present invention also encompasses any isomers or mixtures thereof when prepared according to the present invention.
The Schematic Diagram illustrates the process for the direct method, starting from a cyclic hydroperoxy alkene carboxylic acid, aldehyde, ketone, alcohol, aldehyde acetal and ketone acetal respectively.
04828-TQ/3.2.93 I
S
DIRECr MMTOD
HOG
HO
0 Oxygenation- Cleavage- Cyclization
HO
0
HO
Oxygenation- Cleavage- Cyclization Oxygenation- Cleavage- Cyclization '0-0.
0 H o R OH 0-0, 0 HO0
HOG
RI
,Zo Oxygenation- Cleavage- Pycizaticrn R H, Akyl -V Alk~yl NB: In tis Scheme, one enantiomer only of each chiral compound is depicted. There is also produced an equal amonowt of the other enandomer in each case.
SCHEMATIC DIAGRAM (A) The indirect method involves an esterif ication of the hydroperoxide to give a new intermediate hydroperoxide followed by treatment with one or more cata)osts in the presence of oxygen to undergo a new oxygenat. .n-cleavage reaction and subsequent cyclization to give a cyclic peroxyacetal lactone.
Thus, in another aspect of the invention there is provided a process for preparing a peroxyacetal lactorie compound of ?.formula 6- INO 91/04970 PCT/NU90/00456 (Y)P (CH 2
)M
0 (X)n
R
comprising; esterifying a compound of formula (Y)p/(C 2 HOO (X)n
COOH
to give aL compound of f ormula.
(CH
2
)M
HOO X)n
COOCN
3 ii) oxygenation in the presence of one or more oxidizinig metal citalysts to give compounds of formula (Y)py (CH )m 0Xn-CH HO Xn-fOH H
L
00H 3 0 -7 WO 9 1/04970 PC1'/AU9O/00Q456 f ollowed by iii) treatment with a protic acid or lewis acid to give the desired cyclic peroxy acetal lactone conrpound; where m,n,p,X,Y,R 6and R 7are as defined above.
The following Schematic Diagram illustrates the proces for the indirect mnethod, starting from a cyclic hydropero :y alkens carboxylic acid.
INDRECT METHOD
HOO
HO
Methylation HcO Oxygenation-Cleavage 0 0 0 cid-Catalyzed Cyclization NB: In this Scheme one enantiomer only of each chiral compo';ad is depicted. There is also produced an equal )Vnount of the other en~niomer in ezach case.
SCHEMATIC DIAGRAM (B) 8- WO 91/04970 PCI/A U90/00456 Preferably, the starting hydroperoxide compound is obtained by oxygenation of the corresponding alkene compounds as follows: (CH 2
)M
(Y)p I tzN, (X)n
OH
0 0 Oxygenation Oxygenation (Y)p 1 (X)n
HOO
HO 0 R H. Alkyl IZ 'OH
OR,
OR'
Oxygenation Oxygenation Oxygenation
R
HOO
HOC
RO
R
R' =Alkyl NB: In this Scheme, one enantiomer only of each chiral compound is depicted. There is aio produced an equal amount of the other enantiomer in each case.
9 WO 91/04970 PCT/AU90/00456 Preferably, the alkene carboxylic acid has an alkyl" or other substituent on the double bond and an optionally substituted alkyl chain between the alkene group and the carboxyl group. The alkyl chain preferably contains two, four or more carbon atoms and may also contain one or more heteroatoms such as oxygen. The alkene carboxylic acid may be cyclic or acyclic. The process is preferably carried out as a "one-pot" reaction.
The present invention is particularly suitable for preparing qinghaosu.
According to the process of the invention, the starting material for preparing qinghaosu, comprising the alkene carboxylic acid functionalities is preferably qinghao acid (artemisinic acid or arteannuic acid) of the following formula: Hi Qinghao Acid H
OH
0 Qinghao acid occurs to the extent of 1 3 (dry weight) in Arcemisia annua, which is much greater than the natural occurrence of qinghaosu and is easily extracted from the plant. There have been several attempts carried out elsewhere to convert this compound into qinghaosu, but none is preparatively useful.
Thus, in another aspect of the invention there is provided a process for converting qinghao acid into qinghaosu comprising 10 i) reducing qinghao acid to give d'hydroqinghao acid of formula
H
H
HO
0 Dihydroqinghao acid ii) oxygenating dihydroqinghao acid to give the corresponding hydroperoxides and without isolation iii) oxgenating in the presence of one or more oxidising metal catalysts to give qinghaosu.
Optionally, a protic acid or lewis acid catalyst may be added following step iii).
In a further aspect of the invention there is provided a process for converting qinghao acid into qinghaosu comprising i) reducing qinghao acid to give dihydroqinghao acid; ii) oxygenating dihydroqinghao acid followed by methylation to give the methyl ester hydroperoxide of formula
H
HHO
CHOO
0 Methyl Ester Hydroperoxide iii) oxygenation in the presence of one or more oxidizing metal catalysts to give intermediate products of formulae 11 WO 91/04970 PCT/AU90/00456 and with or without isolation iv) treatment with protic or Lewis acid catalyst to give qinghaosu.
The process of the invention will now be described in more detail in relation to the preparation of qinghaosu.
However, it will be understood, that the invention is not limited to this preparation.
Best Mode of Carrying out the Invention In detail, the process of the invention can be applied to conversion of qinghao acid into qinghaosu according to the direct method as illustrated in the following Schematic Diagram Direct Method for Conversion of Qinghao Acid into Qinghaosu (Artemisinin) H
H
Reduction H 1) Oxygenation H 2) Oxygenation- H OH HO Cleavage- Cyclization
S
Qinghao Acid Dihydroqinghao acid
H
0- 0 0 Qinghaosu SCHEMATIC DIAGRAM (C) 12 WO 91/04970 PCT/AU90/00456 Firstly, qinghao acid is reduced by known methods to give dihydroqinghao acid. This acid is then converted by oxygenation into the new hydroperoxides. Without isolation, the mixture is treated with one or more metal complex catalysts under an oxygen atmosphere and undergoes the new oxygenation-cleavage-cyclization reaction to give qinghaosu.
The preparation of qinghaosu can be carried out according to the indirect method as illustrated in Schematic Diagram Indirect Method for Conversion of Qing ao Acid into Qinghaosu.
Reduction
-OH
H
1) Oxygenation 2) Methylation HOO CH
O
0 Methyl Ester Hyroeroie Methyl Ester Hydroperoxide
O
Qinghao Acid Dihydroqinghao acid Oxygenation-Cleavage H 0 H H H HO 0 CH O 0 CH30 i 0 O Peroxyhemiacetal Dicarbonyl Hydroperoxide Acid-catalyzed Cyclization V cdcaaye Qinghaosu SCHEMATIC DIAGRAM (D) WO 91/04970 3 PCT/AU90/00456 Firstly, qiaghao acid is reduced by known methods to give dihydroqinghao acid. This acid is than converted by oxygenation into the corresponding carboxylic acid hydroperoxides which are then methylated to give the corresponding tertiary hydroperoxide and its regioisomer.
The major tertiary hydroperoxide is than treated with one or more metal complex catalysts under an oxygen atmosphere and undergoes the new oxygen-cleavage reaction to give the corresponding peroxyhemiacetal and the hydroperoxide. These compounds are then cyclized through acid catalysis to give qinghaosu.
Alternatively, the above process can be carried out without first reducing qinghao acid into dihydroqinghao acid, in which case, a compound known as dehydroqin-haosu (artemisitene) is produced.
Without the reduction step, the direct method results in a "one-pot" reaction as illustrated in Schematic Diagram Direct Method for the Conversion of Qinghao Acid into Dehydroqinghaosu (Artemisitene).
H H 1) Oxygenation H 2) Oxygeantion-Cleavage-Cyclzation OH HO oo Qinghao Acid Dehydroqinghaosu SCHEMATIC DIAGRAM (E) Qinghao acid is converted by oxygenation into the hydroperoxides and without isolation, the mixture is treated as described above from the direct method to give dehydroqinghaosu.
14 WO 91/04970 PCT/AU90/00456 By-products of this reaction, not formed in the reaction of the indirect method are new keto-aldehydes of formulae Keto-aldehydes 0 H:
HH
H
0 OH 0 The indirect method for the preparation of dehydroqinghaosu is illustrated in Schematic Diagram Firstly, qinghao acid is converted by oxygenation into the corresponding carboxylic acid hydroperoxides which are then methylated to give the corresponding new tertiary methyl ester hydroperoxide and the mixture of regioisomeric hydroperoxides.
The major, tertiary methyl ester hydroperoxide is then treated with one or more metal complex catalysts under an oxygen atmosphere and undergoes the new oxygenation-cleavage reaction to give a mixture of the peroxyhemiacetal and dicarbonyl hydroperoxide. The peroxyhemiacetal and dicarbonyl hydroperoxide are then cyclized through acid catalysis to give dehydroqinghaosu.
15 WO 91/04970 PCT/A U90/00456 indirect Method for the Conbversion of Qinghao Acid into Dehydroqinghaosu.
H
H 01 0 Qinghao Acid 1) Oxygenation 2) Methylation
H
HOO OCH3 0 Regioisomeric Hydroperoxides Tertiary Hydroperoxide Oxygenation- SCleavage H: 0 H: 1 H00.1 H H I
HO
0OCH 3 0 OCH 2 0 0 Peroxyhemiaceral Dicarbonyl Hydroperoxide Acid-catalyzed Cyckization .0-0) 0, H 0 0 Dehydroqinghaosu SCHEMATIC DIAGRAM (F) WO 91/04970 16 PCT/AU90/00456 A new methyl peroxyacetal whose formula is given below, also forms as a result of the reaction of the peroxyhemiacetal and hydroperoxide with methanol liberated during the ring closure reaction leading to dehydroqinghaosu.
H:
CHO Methyl Peroxyaceta
CH
3 O 0k OCH 0 OCH3 0 The dehydroqinghaosu can be converted according to known methods to give qinghaosu or other active antimalarial compounds.
There are many advantages in using the direct method.
Firstly, the direct method involves a "one-pot" reaction and therefore various isolation and/or purification steps are eliminated.
Secondly, the initial methylation step is eliminated.
The free acid then acts as an internal acid catalyst in the new oxygenation-cleavage-cyclization process. Thus, the need for an external acid catalyst to effect the final ring closure is not essential, but its presence speeds up the cyclization step and improves the overall yield.
The direct method may also be used to p:epare a compound like qinghaosu, but lacking the carbonyl group, and known as deoxoqinghaosu or deoxoartemisinin. The preparation is illustrated in the following Schematic Diagram 17 WO91/04970 PCT/AU90/00456 Direct Method for Conversion of Dihydroqinghao Alcohol into Deoxoqinghaosu (Deoxoarteisinin) H H
H
H Reduction 1) Oxygenation 4 H RedutiH H 0 H 2) Oxygenation- 0
CH
3 O HO H Cleavage- H 0 0 Cyclization Dihydroqinghao Acid Dihydroqinghao Alcohol Deoxoqinghaosu Methyl Ester SCHEMATIC DIAGRAM (G) The qinghao acid is first reduced to dihydroqinghao acid, and then this compound is converted by reduction into the known alkene alcohol we name "dihydroqinghao alcohol" via the dihydroqinghao acid methyl ester. The dihydroqinghao alcohol is then converted by oxygenation into the hydroperoxide mixture, which is treated with one or more complex catalysts under an oxygen atmosphere to give deoxoqinghaosu.
Deoxoqinghaosu is twice as active as qinghaosu as an antimalarial agent.
The oxygenation step of the present invention is preferably photosensitized oxygenation carried out by treating with singlet oxygen in the presence of Rose Bengal.
Preferably, the reaction is carried out in a solvent such as acetonitrile.
Methylation is preferably carried out by treating with diazomethane. This may be prepared from N-nitroso-N-methylurea. The diazomethane is preferably added dropwise in a solution of diethyl ether.
WO 91/04970 18 PCT/AU90/00456 The new oxygenation-cleavage-cyclization and oxygenation-cleavage reactions are typically carried out by treating with one or more oxidizing transition metal complex catalysts such as Cu(OSO2CF 2 Cu(II) propionate, copper(II)2-ethylhexanoate, other copper(II) carboxylate salts, and various iron (TII) salts such as Fe(phenanthroline) 3
(PF
6 3 Other catalysts that may be used are cobalt(II) and cobalt(III) salts. Preferably, this reaction is carried out in a solvent such as acetonitrile and by treating with any one of the above mentioned catalysts, or with a conbination of the copper and iron catalysts. Other suitable solvents include dichloromethane, hexane, ethyl acetate and the like. If the iron catalyst is omitted, then the overall conversion may be somewhat slower. The formation of the cleavage by-products may also be significantly decreased. This results in an increase in the yield of the final product. The new reaction is preferably carried out at a temperature in the range of -300 to -100C and preferably allowed to proceed to completion at room temperature.
The acid-catalysed ring closure is generally carried out in the presence of p-toluenesulfonic acid.
These reactions overall constitute the only known synthesis of dehydroqinghaosu, and provide a convenient means of obtaining this potentially commercially valuable compound in large amounts. The only known source of qinghaosu is the annual shrub Artemisia annua. Because of the large amount of qinghao acid present is Arcemisia annua (up to relative to qinghaosu (up to the above methods will substantially increase the availability of qinghaosu. Moreover, the methods have the potential of providing access to antimalarial agents structurally related to qinghaosu, but possessing enhanced activities.
Specific embodiments of the present invention are illustrated by the following preparative examples. It will be understood, however, that the invention is not confined to the specific limitations set forth in the individual examples.
WO 91/04970 19 PCT/AU90/00456 Example 1 Preparation of Qinghiaosu (Artemisinin) from Qinghao Acid Method 1. Direct Conversion H HI
H
NaBH 4 NiCl 2 I 1) 02, Rose Bengal H
H
H CH 3 OH, 0 °C 2) CH 3 CN, -30 C HOO OH" HOOHN h HO O 0 Qinghao Acid Dihydroqinghao acid Hydroperoxide H 02, Cu(OS0 2
CF
3 2 0.1 eq. 0- O H 0 Qinghaosu
CH
3 CN CH 2 C1 2 -20 OC room H O temperature, 3 h Optically-pure qinghao acid (arteannuic or artemisinic acid), obtained from Artemisia annua, was reduced with sodium borohydride in methanol according to a literature procedure (Xu, Zhu, Huang, Zhou, W.S. Tetrahedron 1986, 42, 819) to dihydroqinghao acid. This was converted into the hydroperoxide in the following way. A suspension of the acid (289 mg, 1.22 x 10 3 mol) in acetonitrile (5 ml) containing Rose Bengal (6 mg) was stirred vigorously under an oxygen balloon at OC whilst under irradiation from a tungsten lamp (500 After 4h a clear solution resulted and the oxygenation was complete. In addition to the tertiary hydroperoxide, the photooxygenation also produces a small amount (ca. 18%) of an allylic regioisomer, which does not undergo the subsequent reactions. Without isolation, the mixture was diluted with dichloromethane (20 mL) and the resulting so!utitn was cooled to -20 OC. A solution containing Cu(OSO 2
CF
3 2 (44 mg, eq.) in acetonitrile (0.5 mL) was added dropwise with stirring. The temperature was held at OC for 1 h and thereafter allowed to rise to room temperature, when the mixture was stirred for a further 2 h. The reaction mixture was poured into water (20 mL) and extracted with ether (2 x 25 mL). The combined extracts were washed with water mL) and brine (10 mL), and then dried (MgSO 4 Evaporation of the solvents left a 20 WO 91/04970 PCT/AU90/00456 viscous oil which after flash chromatography on silica gel with ether-light petroleum (1 1) gave crystalline qinghaosu (arternisinin) (165 mg, lH NMR spectrum (400 MHz, CDC1 3 'H NMP speQ-trum (400 MHz, CDCI 3 5 1.002 (3H, d, Jme-,6 6 Hz, 6.GH 3 1.03-1.12 (2H, in), 1.209 (3H, d, JM, 9 g 7.2 Hz, 9-CH 3 1.33-1.53 (311, mn), 1.446 s, 3-CH 3 1.73-1.81 mn), 1.86-1.93 (lH, in), 1.96-2.09 mn), 2.39-2.48 (Ilh, in), 3.398 (1H, dddd, J8,,8, 7.3, Jsa,8P 7.3, J 8 8 9 J8a,7a, Hz, 118a), 5.862 (1H, s, H1-12).
Addi.-.'n of 0.1 eq. of p-toluenesulfonic acid to the reaction mixture 0.5 h atter addit.zn of the metal catalyst resulted in a more rapid reaction, and formation of the qinghaosu in higher yield.
Example 2 Method 2. Indirect Conversion
HE
H
H.
HO
0 1) 02, Rose Bengal, hu, CH 3 CN, -30 0 C, 4 h' 2) CHAN, ether
H
HOO
CH
3 O0 0 Methyl Ester Hycfroperoxide Dihydroqinghao acid
HE
1) 02, Fe(phen) 3
(PF
6 3 0.03 eq., Cu(OSO 2
CF
3 2 0.1 eq., CH- 3 CN, 0 Oc O O H I 2) p-Toluenesulfonic Acid, 0.3 eq., CH 2 Cl:4, 4 h H Qinghaosu o The dihlydroqingh ao acid (103.1 mg, 4.a6 x 10-4 mol) was photooxygenated as describeu above. The solvent was removed uni vacuum from the reaction mixture to leav the crude mixture of the carboxylic acid hydroperoxide and its regioisomer in a ratio of 4.5: 1, according to lH NMR analysis. The ibture was dissolved in diethyl ether (17.5 mL), and treated dropwise with a solution cr diazoinethane, prepared form N-nitroso-N-inethylurea (350 ing) in diethyl ether (17.5 mL) at 0 OC. Addition of the diazoinethane solution was continued until TLC analysis indicated complete WO 91/04970 21 PCT/AU90/00456 conversion of the free carboxylic acid hydroperoxide into the methyl esters. The mixture was treated with 5% aqueous acetic acid to decompose excess diazomethane.
The resulting mixture was washed with water, aqueous sodium hydrogen carbonate and then brine. The ether solution was dried (MgSO 4 and then evaporated to dryness to give a viscous oil. The major (tertiary) hydroperoxide, a known compound (Jung, El Sohly, HN.; Groom. E.M. J. Org. Chem. 1986, 51, 819) was isolated by flash chromatography on silica gel with diethyl ether light petroleum as the second fraction (72.2 mg, 70%) The hydroperoxide (72.2 mg. 2.55 x 10- mol) in acetonitrile (4 mL) was treated with Fe(phenanthroline) 3
(PF
6 3 (0.03 sq.) in acetonitrile (0.9 mL) followed by Cu(OSO 2
CF
3 2 (0.1 eq.) in acetonitril (0.5 mL) at 0 OC. After 30 min. the reaction r'xture was worked up as described previously to give a crude product, which was dissolved in dichloromethane (20 mL). p-Toluenesulfonic acid monohydrate (15 mg, 7.65 x 10 5 mol) was added, and the resulting mixture was stirred at room temperature for 4h. It was then poured onto an ether-water mixture. The ether layer was separated, and the aqueous layer was extracted with ether. The combined ether layers were proce'sed in the usual way to give the crude product, which was submitted to flash chromatography on silica gel with ether-light petroleum to give qinghaosu as fine needles (20.1 mg, 28% from the hydroperoxide).
Ex.nple 3 Preparation of Dehydroqinghaosu (Arremisitene) from Qinghao Acid Method 1. Direct Conversion H
H
1) 02, Rose Bengal, CH 3 CN, .30 OC. 2 h
H
H 2)02. Fe(phen) 3
(PF
6 3 0.002 eq., Cu(OSO 2
CF
3 2 0.1 eq. 0 H OH HO
SCH
3 CN. 20 OC room temperature, 3 h 0 0 Qinghao Acid Dehydroqinghaosu Qinghao acid (32 mg, 1.37 x 10 4 mol) in acetonitrile (1.5 mL) containing Rose Bengal (ca. 0.5 mg) at -30 DC under oxygen was converted into the free carboxylic acid hydroperoxides corresponding to the methyl ester hydroperoxides described WO l /n-7n0 22 ^vv. ,7| L w u PCT/AU90/00456 below. Without isolation, the mixture was diluted with dichloromethane (5.4 mL) and the resulting solution was cooled to -20 OC. A solution containing Fe(phenanthroline) 3
(PF
6 3 (0.002 eq.) and Cu(OSOICF 3 2 (0.1 eq.) in acetonitrile (0.6 mL) was added dropwise with stirring. The temperature was held at -20 OC for lh and. thereafter allowed to rise to room temperature, when the mixture was stirred for a further two hours. By-products of the reaction, not formed in method 2 below, as detected by thin-layer chromatography of the reaction mixture, were the keto-aldehydes. The 0 H O H H J Keto-aldehydes H H H SOH OH 0 0 reaction mixture was poured into water (10 mL) and extracted with ether (2 x 25 mL).
The combined extracts were washed with water (10 mL) and brine (10 mL), and then dried (MgSO 4 Evaporation of the solvents left a viscous oil which was submitted to flash chromatography on silica gel with ether-light petroleum to give crystalline dehydroqinghaosu (artemisitene) 5 (14.4 mg, 38%).
Example 4 Method 2. Indirect Conversion a) Oxygenation of Qinghao Acid.
H H H 1) 0 2 Rose Bengal, hu h
CH
3 CN, -30 4 h C H
H
OC
H
OH 2) CH 2
N
2 ether OCH 3 HOO OCH 0 0 0 O O O Qinghao Acid Tertiary Hydroperoxide Regioisomeric Hydroperoxides A suspension of qinghao acid (arteannuic or artemisinic acid) (338.2 nig, 1.44 x 10-3 mol) in acetonitrile (35 mL) containing Rose Bengal (6 mg) was stirred vigorously under an oxygen balloon at -30 OC whilst under irradiation from a tungsten lamp (500 After 4h a clear solution resulted and the oxygenation was complete. The 23 WO 91/04970 PCI/A U90/00456 solvent was removed under vacuum to leave the crude mixture of the carboxylic acid hydroperoxides in a ratio of 4.5:1, according to IH NMR analysis. The mixture was dissolved in diethyl ether (17.5 mL), and treated dropwise with a solution of diazomethane, prepared form N-nitroso-N-methyl-urea (350 mg) in diethyl ether (17.5 mnl.) at 0 0 C. Addition of the diazomethane solution was continued until TLC analysis indicated complete conversion of the free cauboxylic acid hydN.operoxides into the methyl esters. The mixture was treated with 5% aqueous acetic acid to decompose excess diazomethane. The resulting mixture was washed with water, aqueous sodium hydrogen carbonate and then brine. The ether solution was dried NMgOW, and then evaporated to dryness to give a viscous oil. The major (tertiary) hydroperoxide, a new compound, was isolated by flash chromato-graphy on silica gel with diethyl ether Ii,,ht petroleum as the second fraction (287.4 mg, 7 'H NMR spectrum (400 M4Hz, CDC1 3 5 0.981 (3H, d, JMe,6 6.4 Hz, 6-CH 3 1.18-1.27 (1Hi, m, H6), 1.209 (3H, s, 3-CH 3 1.27-1.38 1.514 (1H, dddd,ge= 12.5, 12.5, 3.5 Hz, H813), 1.527 (1H, dddd, J =13.0, J 7.3, J 3.0, J 0.8 Hz, 1.72-1.79 B, mn), 1.804 (1H, dddd, 12.3, J& Sa 3.5 =35 J8(, 7 0 Hz, Hga), 1I .134 (1H, dddd, J 12.6. J 3.3, J 3.3 1.971 (1Hi, ddd, J =13. 1, J 10.8. J 3.5 Hz), 2.048 (1H, dddd, J 13.1, J 7.5, J 5.8 Hz), 3.141 (1H, br d, J8,p= 12.6 Hz, H8a), 3.74 1 (3H, s, OCH 3 4.979 (IH, ddd, J12.8a 1.6, J 1.6, J= 1.6, J 0.8 Hz, H12), 5.581 (IH,dd, igem l 1 methiylidene,8a 1.1 Hz, H methylidene), 6.362 (1H, d, 'gem 1. 1 Hz, H methylidene),. 7.575 (1H, br s, W/h/ Hz, OOH).
b) Cleavage-oxygenation to give the peroxyhemiacetal and dicarbonyl hydroperoxide H: 0 H: H 02 ~Fe(phen) 3
(PF
6 3 0.03 eq. HO H H HOCuCOSO 2
CF
3 2 0.1 eq. HO '0 0OH 0 OCH3
OCH
3 ClI 3 CN, 0 Ct I
I
0 30 mm~ 0 Dicarbonyl 0 Terdaqi Hydroperoxide Peroxyhemiacetal Hydroperoxide The tertiar); hydroperoxide (106.3 mng, 3.78 x 10-4 mol) in acetonit-ile (5 mL) was treated with Fe(phenanthroline) 3
(PF
6 3 (0.03 eq. in 0.6 mL. acetonitrile) and then with Cu(OS0 2
CF
3 2 (0.1 eq. in 0.5 mL. acetonitrile) at 0 'C under an oxygen atmosphere.
24 WO 91/04970 PCT/AU90/00456 The reaction mixture was stirred for 30 min with slow warming toward room temperture, and then poured onto a mixture of ether and water. The aqueous phase was extracted with ether and the combined extracts were washed with water until colourless, and then with brine. The organic phase was dried (MgSO 4 and the solvent was removed under reduced pressure to leave a viscous oil, analysis of which by'H NMR spectroscopy indicated that it consisted of predominantly the oxygenaton products. This was isolated by flash chromatography on silica gel with ether-light petroleum as an unstable viscous oil (62.5 mg, Prolonged exposure of the mixture of oxygenation products to silica gel resulted in .'.ecomposition to a more polar product. The oxygenation products were an equilibrium mixture of the peroxyhemiacetal and the free dicarbonyl hydroperoxide. Both are new compounds. IR vm (CHCl 3 3580-3450 (br 3450-3130 (br 3001 2956 2940 2872 2854 1732 1714 (vs) 1627 1443 1285 1167 1100 961 909 cm- 1 1H NMR (400 MHz, CDC1 3 peroxyhemiacetal 6 0.933 (3H, d, JMe, 6 6.4 Hz, 6-CH 3 0.96-1.20 (2H, 1.217 (3H, s, 3-CH 3 1.26-1.39 (3H, 1.56-2.24 (4H, 2.32-2.45 (1H, m, H6), 2.94-3.01 (1H, dd, Jgasp 9.6, JSaBa 7.1 Hz, H8a), 3.804 (3H, s, OCH 3 5.468 (1H, s, methylidene), 6.260 (1H, s, methylidene), 9.617 (11, d, J12, 5 a 2.5 Hz, H12); dicarbonyl hydroperoxide 8 0.991 (3H, d, JMe.6 6.4 Hz, 6-CH). 0.96-1.20 (2H, 1.26-1.39 (3H, 1.56-2.24 (4H, 2.141 (3H, s, 3-CH 3 2.585 (1H, ddd, Jgem 17.6, J4,5 9.3, .4, 5 6.1 Hz, H4), 2.713 (1H, ddd, Jgem 17.6, J4, 5 9.3, J4, 5 6.1 Hz, H4), 3.197 (1H, dd, Jsa,8p 13.3 Jsa,8 3.5 Hz, H8a), 3.840 (3H, s, OCH 3 5.597 (1H, s, methylidene), 6.383 (1H, s, methylidene), 9.340 (1H, dd, J 1.5, J 1.5 Hz, H12), 10399 (1H, s, OOH).
Preirradiation at 6 9.6 (H12, peroxyhemiacetal) resulted in enhancements at 6 5.47 (methylidene, peroxyhemiacetal) of 1% and at 5 3.80 (OCH 3 of 1 3 C NMR spectrum (100 MHz, CDC13), 6 20.049, 20.369, 20.568, 22.070, 22.515, 23.513, 26.986, 27.256, 27.790, 29.644, 29.644, 29.886, 32.078, 33.777, 34.672, 35.144, 40.701, 41.657, 43.407, 43.862, 46.348, 52.278 (OCH 3 peroxyhemiacetal), 52.933
(OCH
3 dicarbonyl hydroperoxide), 58.546, 92.29 (C12a, dicarbonyl hydroperoxide), 92.31 (C12a, peroxyhemiacetal), 105.90 (C3, dicarbonyl hydroperoxide), 125.02 (methylidene C, peroxyhemiacetal), 129.01 (methylidene C, dicarbonyl hydroperoxide), 139.55 (C9, dicarbonyl hydroperoxide), 139.70 (C9, peroxyhemiacetal), 166.20 (C10, peroxyhemiacetal), 170.41 (C10, dicarbonyl hydroperoxide), 201.39 (C12, peroxyhemiacetal), 203.14 (C12, dicarbonyl hydroperoxide), 209.14 (C3, dicarbonyl hydroperoxide).
WO 91/04970 2SPCT/A U90/00456 c) Tandem cyclization of peroxyhemiaceral and dicarbonyl hydro peroxide to deh~ydroqinghaosu (arremisitene).
H0 H.H 0 o HODp-Tcluenesulfoa'ic Acid, 0.3 eq.
HO 0- 0HOH OR CH 2
C
2 4h
H
0 Dicarbonyi 0 Peroxyhemiacetal Hydroperoxide Dehydroqinghaosu The mixture of the peroxyhemiacetal and dicarbonyl hydroperoxide was prepared as described above from the tertiary hyclroperoxide (110.3 mg, 3.92 x 10, mul). The mixture of products was immediately dissolved in dichloromethane (5 m L) and treated with p-toluenesulfonic acid monohydrate (0.3 The resulting mixture was stirred for 4 h at room temperature, and then poured onto an ether-water mixture. The ether layer was separated, and the aqueous layer was extracted with ether. The combined ether layers were processed as described above to give a viscous oil, which upon flash chromatagraphy on silica gel with ether-light petroleum gave dehydroqinghaosu (artemisitine) as fine needles (47.9 mg, 43% from the tertiary hydroperoxide, or 30% from qinghao acid), m.p. 164-166 OC, a known compound. 1H NMR spectrum (400 MvHz, CDC1 3 8 1.017 (3H, d, JMe,6= 5 9 Hz, 6-CH 3 1.15-1.27 1.42-1.63 (3H, m, including H8), 1.43-1.48 (1H, m, H6), 1.459 (3H, s, 3-CH 3 1.72-1.80 (2H, m, including H8), 1.94-2.01 (1H, in), 2.04-2.10 (lH,m), 2.37-2.45 2.550 (1H, dcl, J8,8 13.6, J8,8 4.5 Hz, H8a), 5.672 (1H, dcl, g~em =11 mechylidene,8a 1.1 Hz, methylidene;., 5.995 (1K, s, H12), 6.570 (1H, dd, 1 gem Jmetiylidene,8a 0.5 Hz, H methylidene).
Also formed was the methyl peroxyacetal (17.8 mg, 14%) from the reaction of the peroxyhemniacetal and dicarbonyl hydroperoxide with the methanol formed during the ring closure reaction leading to dehydroqinghaosu.
H:
Methyl Peroxyacetal 0
OCH
3 WO 91/04970 26 PCT/AU90/00456 Example Conversion of Dihydroqinghao Alcohol into Deoxoqinghaosu H H H H LiAlH 4 ether 1; 02. Rose Bengal CH H HO H2) CH 3 CN, -30 OC HO0 cH 3 HO
HO
I hu 0 Dihydroqinghao Acid Dihydroqinghao Alcohol Alcohol Hydroperoxide Methyl Ester
H
02, Cu(OSO 2
CF
3 2 0.2 eq. O-O H Deoxoqinghaosu
CH
3 CN CH 2 Cl2, -20 OC room H O temperature, 2 h Dihydroqinghao alcohol (arteannuinol) was obtained by the reduction of dihydroqinghao acid methyl ester with lithium aluminium hydride in ether according to a literature procedure (Ye, B; Wu, Y. Tetrahedron 1989, 45, 7287).
Dihydroqinghao alcohol (43.9 mg, 1.97 x 10 mol) in acetonitrile (2.5 ml) containing Rose Bengal (ca. 0.5 mg) was then irradiated under oxygen at -30 OC for 2 h to give a hydroperoxide mixture containing predominantly the tertiary hydroperoxide. The mixture was diluted with dichloromethane, cooled to -15 OC and then treated with Cu(OS02CF 3 2 (0.2 eq) in acetonitrile (0.4 ml) for 1 h 45 min, with gradual warming to room temperature. The reaction mixture was quenched with water and then worked up as previously described to give a viscous oil. This was submitted to flash chromatography on silica gel with ether-light petroleum to give deoxoqinghaosu as a white solid (19 mg, 36% from dihydroqinghao alcohol). Spectroscopic data is in agreement with that reported in the literature (Jung, Li., Bustos, D. A.; ElSohly, H. McChesney, J. Tetrahedron Lett. 1989, 30, 5973) 27 WO 91/04970 PCT/AU90/00456 Example 6 Conversion of Model Compound into Peroxyacetal Lactone Method 1. Direct Conversion 0 2 Rose Bengal, hv, CH 3 CN, -40 OC
HOO
HO
OH
0 0 a b 02, Cu(OSO 2
CF
3 2 0.1 eq.
0
CH
3
CN-CH
2 C1 2 0 OC room temp., 4 h. O
HO
C
0 The compound a, a new compound, was obtained from a known mixture of the corresponding methyl ester and a double bond regioisomer of the ester (Claus, P. K.; Vierhapper, F. Wilier, R. L. J. Org. Chem., 1977, 42, 4016), through hydrolysis of the mixture with lithium hydroxide in aqueous dimethoxyethane, and separation of the resulting .'xture of carboxylic acids through an iodolactonization procedure (Corey, E. Wight, S. J. Org. Chem., 1988, 53, 5980). The acid a (134 mg, 7.97 x 10 mol) in acetonitrile (4 mL) containing Rose Bengal (3 mg) under oxygen was irradiated as described below for qinghao acid to give the racemic hydroperoxide b and double bond regioisomers in a ratio of 1:1. The mixture was diluted with dichloromethane (16 mL) and then treated with Cu(OSO 2
CF
3 2 (0.1 eq.) in acetonitrile (0.2 mL) under oxygen at 0 OC. This resulted in the immediate conversion of compound b into a polar intermediate. The other regioisomers of compound b did not appear to react under these conditions. The reaction mixture was allowed to warm to room temperature and was stirred for 4 h. The mixture was poured onto water and extracted with ether as described below for the preparation of qinghaosu to give a viscous oil. This was submitted to flash chromatography with ether-light petroleum 7:3 to give the racemic compound c as a colourless gum (51 mg, 28 WO 91/04970 PCT/AU90/00456 Example 7.
Method 2. Indirect Conversion
OH
1)02, Rose Bengal, hv. CH 3 CN, -40 2) CH 2
N
2 ether
C
HOO
CH O 0 1) 02, Fe(phen)3(PF 6 3 0.03 eq., Cu(OS0 2
CF
3 2 0.1 eq., CH 3
CN
2) p-TsOH, CH 2 C1 2 4 room temperature c 0 The acid a (110 mg, 6.54 x 10 4 mol) was converted into the racemic hydroperoxide b and its mixture of regioisomers as described above. The crude mixture of hydroperoxides was dissolved in ether and treated with an excess of diazomethane at 0 OC.
The racemic ester hydroperoxide d (96 mg, 45%) was isolated by flash chromatography with ether-light petroleum 3:7 of the mixture of ester hydroperoxides obtained after methylation. The hydroperoxide d (96 mg, 4.48 x 10 mol) in acetonitrile mL) under oxygen was treated with Fe(phen) 3
(PF
6 3 (0.03 eq.) in acetonitrile (1 mL) followed by Cu(OSO 2
CF
3 2 (0.1 eq.) in acetonitrile (0.5 mL) at 0 After 30 min, the reaction mixture was worked up to leave the crude product mixture consisting of a peroxy hemiacetal and hydroperoxide analogous to those described for the indirect conversion of qinghao acid into dehydroqinghaosu (artemisitene) described below. A solution of the mixture in dichloromethane (20 mL) containing p-toluenesulfonic acid (26 mg, 1.34 x 10 4 mol) was stirred for 4 h at room temperature. Workup as previously described gave a viscous oil which after purification by flash chromatography with ether-light petroleum 7:3 gave the racemic peroxyacetal lactone c (48 mg, 50% from a).
29 -Characterising data for compound c in examples 6 and 7 4 C 0 IR Vma (CEC1 3 2936 in, 2869 w, 1770 vs, 1451 w, 1295 w, 1239 mn, 1211 mn, 1193 mn, 1l 6 4 m, 1099 w, 962 w, 941 w, 914 wcm-1. 1 F NMR 5 1.5 1.7(mi, s, CE 3 1.7 -2.0 (in, H4 and H6), 2.1 (2H, t, J 4 ,3 8.2 Hz, 2.6 (2H, t, JT' 8.2 Hiz, H3T), 5.4 (lE, s, 13 C NMIRa 19.6, C5; 2j.6, CE- 3 29.0, CE 2 29.7, 2 X CH 2 34.4, C3T; 84.7, C7; 123. 1, C6'; 141.3, C3; 176.5, CT'.
Mass spectrum m/z: 219 213 185 181 167 (100), 153 149 121 (17), 83 71 61 (41).
Example 8 Conversion of the dimethyl acetal into artemether For Scheme see next page The dimethyl acetal of dihydroqinghao aldehyde was obtained by oxidising dihydroqinghao alcohol under Swern conditions and then stirring the resulting aldehyde in methanol in the presence of Dowex acidic resin. The dimethyl. acetal (49 mg;, 0.18 inmol) was irradiated in the presence of Rose Bengal in a mixture of acetonitrile (1.5 ml) and dichloromethane (0.5 ml) under an oxygen atmosphere at below -300. After 2 h when the conversion into the hydroperoxides was complete the reaction mixture was diluted with dichioromethane (7 ml) and then copper(LE) tifluoromethanesulfonate (0.018 minol; 0.18 ml, 0.1 M in acetohifrile) was added at -200. Stirring was continued at this temperature for 1 h before the reaction mixture was allowed to warm to room temperature and quenched by pouring onto ether/water. The usual workup afforded a viscous oil which was purified by flash chromatography on silica gel with ether-light petroleum 15:85 to'give l3-arteinether as the first fraction and as a crystalline solid (6.2 mg; 11%) and a mixture containing cc-artemether and its rearrangement producL, the peroxyacetal, in a ratio of 1: 1 (7 mg, Spectroscopic data obtained for bo th epirners of artemether were in agreement with that reported in the literature (1i, Yu, P. Chen, Y. Li, L.
Gal, Y. Wang, D. Zheng, Y. Kexue Ton gbao 1979, 24, 667).
30 DOWEX SOW methanol dihydroqinghao aidehyde .dimethyl acetal 0,Rose Benigal, hv, H E CH 3 CN, -Sao H acetal hydroperoxide HO00
CH
3 0 CICHa 02, Cu(OSO 2
CF
3 )q 2 0.1 eq. CH- 3 CN CH 2 01 2 -200 room temperature HE HE
OCH
3 P-artemether OCH3 a-artemether peroxyacetal 31 Example 9 Conversion of the diethyl acetal into arteether diethyl acetal OEt r3-arteether OEt c-arteether peroxyacetal The diethyl acetal of dihydroqinghao aldehyde (23.6 mg; 0.083 mmol), prepared in an analogous manner to that of the dimethyl. acetal, was treated as described for the dimethyl acetal to give farteether (2 mg; as a crystalline solid and a mixture containing Cc-arteether and its rearrangemer' product, the peroxyacetal in a ratio of 18:82 (5.6 mg; Spectroscopic data obtained for both epimers of arte ether were in agreement with that reported in the literature (Li, Yu, P. Chen, Y.
X; Li, L. Gai, Y. Wang, D. Zheng, Y. Acta. P harm. Sinica 1981, 16, 429).
Claims (5)
1. A process of preparing a compound of formula I(CH 2 )m 0-0 (X)n 0'--77R6 R wherein n 1, 2 or 3 m 0, 1 or 2 p 0, 1, 2 or 3 X CR
2 R
3 CCR 2 R 3 S, SO or SO 2 where R 2 and R 3 are independently selected from H, optionally substituted alkyl, optionally substituted aryl, the optional substituents being selected from alkyl, aryl, halogen, OR, CF 3 NO 2 COR, NRR', SR, COOR, CONRR', SO 3 R, S02NRR', SR, SOR and SO 2 R, where R and R' are H, alkyl, aryl or arylalkyl; SR", SOR", SO 2 R" where R" is alkyl or aryl optionally substituted by one or more substituents selected from alkyl, aryl, halogen, OR, CF 3 NO 2 COR, NRR', SR, COOR, CONRR', SO 3 R, SO 2 NRR', SR, SOR and SO 2 R, where R and R' are as defined above; and wherein when n>l, X is independently selected and can be branched or straight chain and X together with a substituent Y can also form a ring; Y is a substituent selected from H; alkyl or aryl optionally substituted by one or more substituents selected from alkyl, aryl, halogen, OR, CF 3 NO 2 COR, NRR', SR, COOR, CONRR', S03R, SO 2 NRR', SR, SOR and SO 2 R, where R and R' are as defined above;
04828-TQ/31.5.93 33 Y can be on the same C atom as the hydroperoxy group and any C atom may be disubstituted by Y and includes replacement of H atom(s) in "(CH 2 by Y; R 6 or R 7 is as defined for R above, H, OH, OR 1 or together with the carbon atom to which they are attached form a keto group, where.R 1 is alkyl, aryl or aralalkyl; which comprises oxygenating a compound of formula (CH,)m I HQ O O (X)n R in the presence of one or more oxidizing metal catalysts where OR 1 R 5 -COOH, -CROH, -C-R \OR1 where R is H, alkyl, aryl or arylalkyl R 1 are independently alkyl, aryl, arylalkyl or each R 1 together with the group to which they are attached form a cyclic acetal. 2. A process according to claim 1 wherein the catalyst is selected from one or more oxidizing transition metal complex salts of Copper(II), Iron(III), Cobalt(II) and Cobalt(III). 3. A process according claim 1 or 2 wherein the catalyst is one or more transition metal complex catalysts selected from Cu(OSO 2 CF 3 Cu(II)propionate, Cu(II) 2-ethylhexanoate, other Cu(II)carboxylate salts, Fe(phenanthroline) 3 (PF 6 3 and other iron(III) salts.
4. A process according to any one of the preceding claims further comprising the addition of a protic acid or lewis 04828-TQ/31.5.93 S34 acid catalyst. A process according to any one of the preceding claims wherein the startiag hydroperoxy functionality containing compound is derived by oxygenation of the corresponding compound containing alkene carboxylic acid, alkene aldehyde, alkene ketone, alkene alcohol functionality or dialkyl acetals of the aldehyde and ketone compounds. 6. A process according to claim 5, wherein the starting compound is deived by oxygenation of a compound of formula (CH )m O (X)n I- R where.in m, n, p, X, Y and R 5 are as defined above. 7. A process for preparing a peroxyacetal lactone compound of formula (Y)p (cH) -O R 7 wherein m,n,p,X,Y,R 6 and R 7 are as defined above; comprising; i) esterifying a compound of formula (CH 2 )m H o (X)n COOH 04828-TQ/31.5.23 to give a compound of formula (CH 2 )m HO (X)n C000H 3 followed by ii) oxygenating in the presence of one or more oxidizing metal catalysts to give compounds of formula (H )m (Yp(CHj 2 )m XnOCH 3 a 4 HOO (XnOH HOX Xn rOH 0 0 0 iii) treating with protic acid or Lewis acid catalyst to give the desired cyclic peroxy acetal lactone compound. 8. A process according to~ claim 7 wherein the metal catalyst is one or more transition metal complex catalysts selected from Cu(0S0 2 CF 3 2 1 Cu(II)propionate, Cu(II) 2-ethylhexanoate, other C-u(II)carboxylate salts, Fe (phenanthroline3) 3 (PF6) and other iron (III) salts. 9. A process f or converting ginghao acid into qinhaosu compris in~g i) reducing qinghao acid to give dihydroqinghao acid of f or- mul1a H H H HO 0 Dihydroqinghao' acid 048 28-TQ/3 1.5,93 36 ii) oxygenating dihydroqinghao acid to give the corresponding hydroperoxi-es and without isolation iii)oxgenating in the presence of one or more oxidising metal catalysts to give qinghaosu. 10. A process according claim 9 wherein the catalyst is one or more transition metal complex catalysts selected from Cu(OSO 2 CF 3 2 Cu(II) propionate, Cu(II) 2-ethylhexanoate, other Cu(II) carboxylate salts, Fe(phenanthroline) 3 (PFg) 3 and other iron (III) salts. 11. A process according to claim 9 or 10 further comprising the addition of a protic acid or lewis acid catalyst following step iii). 12. A process for converting qinghao acid into qinghaosu comprising i) reducing qinghao acid to give dihydroqinghao acid; ii) oxygenation of dihydroqinghao acid followed by methylation to give the methylester hydroperoxide of the formula H H H HOO CZ'O:i cH, 3 0 0 iii) oxyqenation in the presence of one or more oxidizin. metal catalysts to give intermediate products of formulae H O H i o.00 H HOO H H H Ho 0 CH.O CHO 0 0 'eroxyheTiacea Dicarbonyl Hydroperoxide 04828-TQ!31.5.93 37 and with or without isolation iv) treatment with protic or Lewis acid catalyst to give qinghaosu. 13. A process according to claim 12 wherein the metal catalyst is one or more transition metal complex catalysts selected from Cu(OSO 2 CF 3 2 Cu(II) propionate, Cu(II) 2-ethylhexanoate, other Cu(II) carboxylate salts, Fe(phenanthroline)3 (PF 6 3 and other iron (III) salts. 14. A process for converting qinghao acid into dehydroqinghaosu comprising i) oxygenation to give the intermediate hydroperoxide ii) oxygenation in the presence of one or more metal catalysts to give the desired product of formula Hi o A process according to claim 14 wherein the catalyst is one or more transition metal complex catalysts selected from >I.(OS0 2 CF 3 2 Cu(II) propionate, Cu(II) 2-ethylhexanoate, other Cu(II) carboxylate salts, Fe(phenanthroline)3(PF6)3 and other iron (III) salts. 16. A process according to claim 14 or 15 further comprising the addition of a protic acid or Lewis acid catalyst following step ii). 17. A process for converting qinghao acid into dehydroqinghaosu comprising 04828-TQ/31.6.93 38 i) oxygenation of qinghao acid into the hydroperoxides followed by methylation to give a compound of formula H HOO OCH 3 0 Tertiary Hydroperoxide ii) oxygenation in the presence of one or more oxidizing metal catalysts to give intermediate products of formulae Hi 0 H HOO H H HO 0 OCH 0 OCH3 0 0 and with or without isolation iii)treatment with protic or Lewis acid catalyst to give dehydroqinghaosu. 18. A process according to claim 17 wherein the metal catalyst is one or more transition metal complex catalysts selected from Cu(OSO 2 CF 3 2 Cu(II) propionate, Cu(II) 2-ethylhexanoate, other Cu(II) carboxylate salts, Fe(phenanthroline) 3 (PF 6 3 and other iron (III) salts. 19. A compound of formula o H HCO H 0 OCH, 04828-TQ/31.5.93 39 A compound of formula H H H 0 OCHO OHO 0 21. A compound of formula 0-0 0 HO o 0 22. A process of preparing deoxoqinghaosu comprising i) oxygenation of dihydroqinghao alcohol to give the intermediate hydroperoxides followed by ii) oxygenation in the presence of one or more metal catalysts to give the desired product of formula H 0-0, Deoxoqinghaosu 0- H 0 23. A process according to claim 25 wherein the metal catalyst is one or more transition metal complex catalysts selected from Cu(OSO 2 CF 3 2 Cu(II) propionate, Cu(II) 2-ethylhexanoate, other Cu(II) carboxylate salts, Fe(phenanthroline) 3 (PF6) 3 and other iron (III) salts. 24. Qinghaosu when prepared by a process according to any one of claims 1-8. 25. Qinghaosu when prepared by a process according to any one of claims 9-13. 04828-TQ/31.5.93 40 26. Deoxoqinghaosu when prepared by a process according to claim 22 or 23. 27. Dehydroqinghaosu prepared by a process according to any one of claims 14-18. 28. A process of preparing a compound comprising a peroxyacetal lactone functionality from a compound comprising hydroperoxy alkene carboxylic acid functionalities substantially as described with reference to any one of examples 1 4, 6 or 7. 29. A process of preparing a compound comprising a peroxyacetal ether functionality from a compound comprising hydroperoxy alkene alcohol functionalities substantially as described with reference to example A process of preparing qinghaosu substantially as described with reference to example 1 or 2. 31. A process of preparing dehydroqinghaosu substantially as described with reference to example 3 or 4. 32. A process of preparing deoxoqinghaosu substantially as described with reference to example Dated this 31 May 1993 RHONE-POULENC RORER S.A. By their Patent Attorney Griffith Hack Co. 04828-TQ/31.5.93 XNTERNAI'XONAX SUA1rCI Rer International Application No. PCT/AU 90/00456 I. CLASSIFICATION OF SUBJECT MATTER (if several classification symbols apply, indicate all) 6 According to International Patent Classification (IPC) or to both National Classification and IPC 5 Int. C1.
5 C7D 321/10, 493/18, 497/18; C07C 409/14 II. FIELDS SEARCHED Minimum Documentation Searched 7 CLassification System Classification Symbols IPC C07D 321/10, 493/18, 497/18; C07C 409/14 IPC C07C 179/053 PC-3 C07C 179/02 IP C07C 73/06 Documentation Searched other than Minimum Documentation to the Extent that such Documents are Included in the Fields Searched 8 I AU IPC as above; Australian Classification 09.33, 09.353 III. DOCUMENTS CONSIDERED TO BE RELEVANT 9 Category* I Citation of Document, with indication, where appropriate, Relevant to Sof the relevant passages 12 CLaim No 13 P,X Journal of the Chemical. Society; Chemical Cammnications, 1990, (1,3 to 5,10 to 23, No.6, issued 15 March 1990 (Cambridge, R.K. Haynes, 27,28,30 to 32) S.C. Vonwiller, 'Catalysed Oxygenation of Allylic Hydroperoxides a, Derived from Qinghao (Artemisinic) Acid. Conversion of Qinghao Acid into Dehydroqinghaosu (Artemisitene) and Qinghaosu (Artemisinin)', see pages 451 to 453, particularly page 452, compounds 4 to 6,8 P,X Tetrahedron Letters, Volume 30, No. 44, issued November 1989, (1,5,21) (Oxford, 'A Short and Stereospecific Synthesis of Deoxoartemisinin and (-)-deaodesoxyartemisinin', see pages 5973 to 5976, especially page 5974, cmpound 8 (ccntinued) Special categories of cited documents: 10 later document published after the international filing date or priority date document defining the general state of the and not in conflict with the application but art which is not considered to be of cited to understand the principle or theory particular relevance underlying the invention earlier document but published on or document of particular relevance; the after the international filing date claimed invention cannot be considered novel document which may throw doubts on priority or cannot be considered to involve an claim(s) or which is cited to establish the inventive step publication date of another citation or document of particular relevance; the other special reason (as specified) claimed invention cannot be considered to document referring to an oral disclosure, involve an inventive step when the document use, exhibition or other means is combined with one or more other such document published prior to the documents, such combination being obvious to international filing date but later than a person skilled in the art. the priority date claimed document member of the same patent family IV. CERTFICATION Date of the Actual Completion of the Dte of Mailing of this International International Search Search Report I Zl ,h mbr o199 International Searching Authority Signature of Authorized Officer Australian Patent Office A. PECK Form PCT/ISA/210 (second sheet) (January 1985) International Ap( ation No, PCT/A 90/00156 SURToER INFRMAITION CO UED FROM HE SECND SEET A Journal of Organic Chemistry, Volume 51, No.26, issued December (1) 1985 (Columbus Ohio, M. Jung et al., 'Practical Conversion of Artemisinic Acid into Desaoyartemisinin', see pages 5417 to 5419 A Pure Applied Chemistry, Volume 58, No.5, issued 1986, (Oxford, (1,20) W.S. Zhou, 'Total Synthesis of Arteanuuin (Qinghaosu) and SRelated Compounds', whole document (review article), pages 817 to S824, especially page 823, Scheme 8, compound A II V. OBSERVATIONS HERE CERTAIN CLAIMS WERE FOUND UNSEARMHABLE 1 This international search report has not been established in respect of certain claims under Article 17(2)(a) for the following reasons: claim numbers because they relate to subject matter not required to be searched by this Authority, namely: Claim numbers because they relate to parts of the international application that do not comply with the prescribed requirements to such an extent that no meaningful international search can be carried out, specifically: Claim numbers because they are dependent claims and are not drafted in accordance with the second and third sentences of PCT Rule 6.4 VI. OBSERVATIONS WHERE UNITY OF ~WENTION IS LAKING 2 This International Searching Authority found multiple inventions in this international application as follows: The application claims two distinct inventions distinguished by the structural differences betWeen the heterocyclic lactone and ether compounds (claims 1 to 19,22 to 35), and the alicyclic cyciohexane and hydrogenated naphthalene derivatives (claims 20,21). As all required additional search fees were timely paid by the applicant, this international search report covers all searchable claims of the international application. 3 As only some of the required additional search fees were timely paid by the applicant, this international search report covers only those claims of the international application for which fees were paid, specifically claims: No required additional search fees were timely paid by the applicant. Consequently, this international search report is restricted to the invention first mentioned in the claims; it is covered by claim numbers: 4. As all searchable claims could be searched without effort justifying an additional fee, the International Searching Authority did not invite payment of any additional fee. Remark on Protest The additional search fees were accompanied by applicant's protest. No protest accompanied the payment of additional search fees. Form PCT/ISA/210 (supplemental sheet (January 1985)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU64475/90A AU640171B2 (en) | 1989-09-27 | 1990-09-27 | Cyclic peroxyacetal lactone, lactol and ether compounds |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ6595 | 1989-09-27 | ||
| AU659589 | 1989-09-27 | ||
| AU64475/90A AU640171B2 (en) | 1989-09-27 | 1990-09-27 | Cyclic peroxyacetal lactone, lactol and ether compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6447590A AU6447590A (en) | 1991-04-28 |
| AU640171B2 true AU640171B2 (en) | 1993-08-19 |
Family
ID=25611877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU64475/90A Ceased AU640171B2 (en) | 1989-09-27 | 1990-09-27 | Cyclic peroxyacetal lactone, lactol and ether compounds |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU640171B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07500325A (en) * | 1991-10-14 | 1995-01-12 | ザ ユニバーシティ オブ シドニー | Cyclic peroxyacetal compound |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU629571B2 (en) * | 1988-10-04 | 1992-10-08 | Hoechst A.G. | Novel artemisinin derivatives, processes for their preparation and their use as antiprotozoal agents |
-
1990
- 1990-09-27 AU AU64475/90A patent/AU640171B2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU629571B2 (en) * | 1988-10-04 | 1992-10-08 | Hoechst A.G. | Novel artemisinin derivatives, processes for their preparation and their use as antiprotozoal agents |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6447590A (en) | 1991-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Terent'ev et al. | Synthesis of five-and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products | |
| Tius et al. | Total synthesis of (+)-desepoxyasperdiol | |
| US5334740A (en) | Cyclohexanetriol derivatives | |
| Semmelhack et al. | Synthesis of racemic fomannosin and illudol using a biosynthetically patterned common intermediate | |
| US4395560A (en) | Preparation of 6a,10a-trans-hexahydrodibenzopyranones | |
| US5420299A (en) | Cyclic peroxyacetal lactone, lactol and ether compounds | |
| AU640171B2 (en) | Cyclic peroxyacetal lactone, lactol and ether compounds | |
| Yadav et al. | Cyclopentane synthesis and annulation II: Radical cyclizations of oxathiolanones | |
| Srinivas et al. | Stereoselective total synthesis of (+)-varitriol | |
| RU2098407C1 (en) | Method of synthesis of peroxyacetal lactone compound (variants) and lactone | |
| EP0061209A1 (en) | Novel prostaglandin analogues and process for making same | |
| White | A Synthetic Entry to the Trichothecene Nucleus via Cargill Rearrangement. Formal Synthesis of (±)-Verrucarol | |
| Simonovic et al. | Terpenoids—XXXIX: The synthesis of tetrahydrosaussurea lactone | |
| Sumiya et al. | Stereoselective synthesis of (±)-urechitol A employing [4+ 3] cycloaddition | |
| Cantrell | Reactivity of photochemically excited 3-acylthiophenes, 3-acylfurans, and the formylthiophenes and furans | |
| Kigoshi et al. | Novel Transformation of Formyl Groups into Hydroxyl Groups Utilizing Deformylative Autoxidation of Aldehydes. | |
| Takeshita et al. | Synthetic photochemistry. XIX. The synthesis of protoilludanes by photocycloadditions. Protoillud-7-ene and several oxygenated derivatives. | |
| Brown | Epimerization in acid degradation products of artemisinin | |
| Hagiwara et al. | A facile synthesis of 5-methyl-6, 8-dioxabicyclo [3.2. 1] octan-3-ones from 4-(t-butyldimethylsiloxy) pent-3-en-2-one and protected α-ketols. A synthesis of (±)-frontalin | |
| Blay et al. | Synthesis of torrentin, dihydrosantamarine, and saussurea lactone from santonin | |
| US3824291A (en) | 4-(3-hydroxy-1,5-dimethylhex-1-yl)-1-cyclohexene-1-carboxaldehyde | |
| Blackburn et al. | Synthetic approaches to phomactins: Novel oxidation of homoallylic alcohols using tetra-n-propylammonium perruthenate | |
| DE2166797C2 (en) | Optically active tricyclic lactonaldehydes and processes for their preparation | |
| Fernández-Mateos et al. | Synthesis of the insect antifeedant CDE molecular fragment of 12-ketoepoxyazadiradione and related compounds | |
| MATOBA et al. | Chemistry of 2-Methoxy-2, 5-cyclohexadienone. V. Photochemical Rearrangement and Oxidation of 2-Methoxy-4-methyl-4-phenyl-2-cyclohexenone and 2-Methoxy-4-methyl-4-phenyl-2, 5-cyclohexadienone |